Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00010192
Status:
COMPLETED
Last Update Posted:
2013-06-06
First Post:
2001-02-02
Brief Title:
Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer
Sponsor:
Organization:
National Cancer Institute NCI